Biomedicum Helsinki Day 2025

Olli Kallioniemi is Research Director at the Institute for Molecular Medicine Finland (FIMM), part of HiLIFE at the University of Helsinki. He received his MD and PhD from the University of Tampere and spent over a decade in the United States as a postdoctoral fellow and tenure-track investigator. From 2007 to 2015, he served as the founding director of FIMM and later became Director of the Science for Life Laboratory (SciLifeLab), Sweden’s national infrastructure for life science research (2015–2024), as well as Founding Director of the national Data-Driven Life Science (DDLS) program. His return to Finland has been supported by the BrainGain grant from the Sigrid Jusélius Foundation, the Jane and Aatos Erkko Foundation, and the Finnish Medical Foundation. His research focuses on AI- and data-driven precision medicine, particularly in acute myeloid leukemia and prostate cancer, and he co-leads a national initiative on the future use of Finnish health data. Kallioniemi has authored over 420 publications, supervised 27 doctoral theses, and several patents as well as received several international awards. He is a member of EMBO, the European Academy of Cancer Sciences, the Royal Swedish Academy of Sciences, and the Nobel Assembly at Karolinska Institutet.